ArticleDisease markers2021

Overexpression of CXCR7 is a Novel Indicator for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Patients.

Yong Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.